The Transfusion Innovation Department works in collaboration with project teams at national headquarters to test and evaluate new technologies and processes being considered for use by ARC Biomedical Services (ARCBS) for the collection, processing and testing of blood and blood components. Typical projects include:
- A new collection set recently assessed for the collection and manufacture of leukoreduced blood, now being used by ARCBS.
- A new instrument to count residual levels of white blood cells in leukoreduced blood components recently implemented by ARCBS.
- A new pathogen reduction technology for platelets, now being used by ARCBS